Death rates for the most common type of lung cancer are on the decline, likely due to a decrease in incidence and advance in treatments, a new study suggests. For the study, published in the New ...

Researchers from The University of Texas MD Anderson Cancer Center have discovered that some cancer cells express the YAP1 protein only after treatment with chemotherapy, allowing them to survive by ...

Lung cancer is now the leading cause of cancer deaths in the U.S., claiming more lives than breast, ovarian and uterine cancers combined. Cases are rising among young adults and people who have never ...

A study linked YAP1-positive cancer cells to chemotherapy resistance and invasive behavior in relapsed small cell lung cancer ...

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living with small cell lung cancer (SCLC). However, its cost raises questions about ...

Add Yahoo as a preferred source to see more of our stories on Google. A new study from the American Cancer Society is shedding light on cancer mortality rates among young people — and the one type of ...

Trudy Oliver, professor of pharmacology and cancer biology, is part of a team of scientists that recently published a study uncovering a major shift in how scientists understand small-cell lung cancer ...

SCLC diagnosis involves imaging, biopsies, and lab tests to assess tumor spread and guide treatment decisions. Treatment options vary by stage, with surgery, chemotherapy, radiation, and immunotherapy ...

Results of a new study conclude that a pathology tool powered by artificial intelligence can predict whether a patient with extensive-stage small cell lung cancer will respond to platinum-based ...